Research Information System
IZMIR DR BEHCET UZ COCUK HASTANESI DERGISI, no.3, pp.177-183, 2015 (ESCI, TRDizin)
Objective: With development of newer devices and techniques, transcatheter closure of patent ductus arteriosus (PDA) has been established as a first choice treatment. In this study, cases with PDA who were closed using Amplatzer duct occluder I(ADO), and II (ADO II) are presented, and the efficacy and safety of closure of PDA using these devices are discussed. Methods: Eighty-two patients (13 ADO, 69 ADO II) underwent transcatheter closure between January 2010 and April 2015, PDA closure was successful in 81 patients. We retrospectively reviewed these cases. Results: Median age of our patients was 3 years (7 months-16 years). Narrowest diameter of PDA was 2.39 +/- 0.91 mm. Duration of the procedure and fluoroscopy were 55 mins and 11 mins, respectively. Procedure was successful in 98.8% of the cases. In successful 81 cases, ADO was used in 12, ADO II in 69 cases. As a minor complication, only 5 patients had minimal residual shunt during the acute period. Residual shunt was completely disappeared in 4 patients. The only major complication in our study was device embolisation which occurred in one patient which was closed with ADO. In this case, device was removed using snare, and PDA was closed with surgical intervention. Conclusion: Nowadays, PDA closure has been currently applied with success in many centres. In this study, we reviewed cases who had undergone PDA closure using ADO and ADO II devices during the last five years. Based on findings of our study, we suggest that transcatheter closure of PDA using ADO I, and ADO II devices is safe and reliable option with low complication rate which is consistent with the literature findings.